RBEL1 is required for osteosarcoma cell proliferation via inhibiting retinoblastoma 1 is a research paper published in Molecular Medicine Reports (2016). On theSindex it has a DataRank of 1.3. It has been cited 29 times, with 23 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0.803
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 23 citers.
FWCI
0.66
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 3 of High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
Additional file 3 of High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
Additional file 2 of High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
Additional file 2 of High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
Additional file 1 of High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
Additional file 1 of High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma